Improvement in patient‐reported “taste” and association with smell in dupilumab‐treated patients with severe chronic rhinosinusitis with nasal polyps from the SINUS‐24 and SINUS‐52 trials
暂无分享,去创建一个
A. Peters | S. Fujieda | E. Heffler | A. Lane | Z. Soler | L. Crampette | R. Kern | J. Maspero | P. Rowe | Asif H Khan | Y. Deniz | S. Siddiqui | S. Nash | J. Jacob-Nara | H. Zhang | J. Máspero
[1] A. Praestgaard,et al. Rapid and sustained effects of dupilumab in severe chronic rhinosinusitis with nasal polyps , 2021, International forum of allergy & rhinology.
[2] A. Murphy,et al. Dual blockade of IL‐4 and IL‐13 with dupilumab, an IL‐4Rα antibody, is required to broadly inhibit type 2 inflammation , 2019, Allergy.
[3] C. Bachert,et al. The Global Allergy and Asthma European Network (GALEN rhinosinusitis cohort: a large European cross-sectional study of chronic rhinosinusitis patients with and without nasal polyps. , 2019, Rhinology.
[4] Timothy L. Smith,et al. Taste impairment in chronic rhinosinusitis , 2018, International forum of allergy & rhinology.
[5] L. Rudmik,et al. Prevalence of polyp recurrence after endoscopic sinus surgery for chronic rhinosinusitis with nasal polyposis , 2017, The Laryngoscope.
[6] S. Nguyen,et al. The prevalence of olfactory dysfunction in chronic rhinosinusitis , 2017, The Laryngoscope.
[7] Z. Soler,et al. Medical Therapies for Adult Chronic Sinusitis: A Systematic Review. , 2015, JAMA.
[8] C. Hopkins,et al. Prevalence of sinonasal outcome test (SNOT‐22) symptoms in patients undergoing surgery for chronic rhinosinusitis in the England and Wales National prospective audit , 2012, Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery.